Home Cart Quotation Policy About-Us
www.ChineseStandard.net
Database: 221581 (27 Mar 2026)
SEARCH
Path: Home > YY/T > Page1 > YY/T 1584-2018

YY/T 1584-2018 PDF English

Price & Delivery

US$159.00 · In stock · Download in 9 seconds
YY/T 1584-2018: Retinol binding protein testing kit(immune turbidity method)
Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See step-by-step procedure
Status: Valid
Std IDVersionUSDBuyDeliver [PDF] inTitle (Description)
YY/T 1584-2018English159 Add to Cart 3 days [Need to translate] Retinol binding protein testing kit(immune turbidity method)

Click to Preview a similar PDF

Basic data

Standard ID YY/T 1584-2018 (YY/T1584-2018)
Description (Translated English) Retinol binding protein testing kit(immune turbidity method)
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C44
Classification of International Standard 11.100
Word Count Estimation 8,818
Date of Issue 2018-02-24
Date of Implementation 2019-03-01
Quoted Standard GB/T 191; GB/T 29791.2
Regulation (derived from) China Food and Drug Administration announced No. 27 of 2018
Issuing agency(ies) State Food and Drug Administration
Summary This standard specifies the requirements for retinol-binding protein assay kits (immunoturbidimetry), test methods, labels, labels and instructions for use, packaging, transportation, and storage. This standard applies to spectrophotometer or biochemical analyzer using immunoturbidimetry (such as immune transmission turbidimetry, latex enhanced immunoturbidimetry, etc.) determination of serum samples retinol binding protein assay kit (hereinafter referred to as "RBP kit Retinol binding protein assay kit (hereinafter referred to as "URBP kit") and urine sample. This standard does not apply to the evaluation of retinol-binding protein calibrators and controls.

YY/T 1584-2018: Retinol binding protein testing kit(immune turbidity method)


---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Retinol binding protein testing kit(immune turbidity method) ICS 11.100 C44 People's Republic of China Pharmaceutical Industry Standard Retinol binding protein assay kit Published on.2018-02-24 2019-03-01 implementation State Food and Drug Administration issued

Foreword

This standard was drafted in accordance with the rules given in GB/T 1.1-2009. Please note that some of the contents of this document may involve patents. The issuing organization of this document is not responsible for identifying these patents. This standard was proposed by the State Food and Drug Administration. This standard is under the jurisdiction of the National Medical Clinical Laboratory and the In vitro Diagnostic System Standardization Technical Committee (SAC/TC136). This standard was drafted. Beijing Medical Device Inspection Institute, Ningbo Meikang Biotechnology Co., Ltd., Shanghai Kehua Biological Engineering Unit Co., Ltd., Beijing Lidman Biochemical Co., Ltd., Beijing Jiuqiang Biotechnology Co., Ltd. The main drafters of this standard. Li Zheng, Zou Bingde, Xiao Lusheng, Ren Yikun, Cai Huaya. Retinol binding protein assay kit (immunoturbidimetry)

1 Scope

This standard specifies the requirements, test methods, labels, labels and instructions for use of the retinol binding protein assay kit (immunoturbidimetry). Book, packaging, transportation and storage. This standard applies to immunoturbidimetric methods for spectrophotometers or biochemical analyzers (eg immunoturbidimetry, latex-enhanced immunoturbidimetry) Etc.) Determination of retinol-binding protein assay kit (hereinafter referred to as "RBP kit") in serum samples and retinol-conjugated eggs in urine samples White assay kit (hereinafter referred to as "URBP kit"). This standard does not apply to the evaluation of retinol binding protein calibrators and controls.

2 Normative references

The following documents are indispensable for the application of this document. For dated references, only dated versions apply to this article. Pieces. For undated references, the latest edition (including all amendments) applies to this document. GB/T 191 packaging storage and transportation icon GB/T 29791.2 Information provided by in vitro diagnostic medical device manufacturers (labeling) Part 2. Professional in vitro diagnostic reagents

3 requirements

3.1 Appearance The components of the kit should be complete and complete, and the liquid should be free of leakage. 3.2 Loading The liquid content in the kit should be no less than the indicated value. 3.3 Reagent blank absorbance Should meet the requirements of the manufacturer. 3.4 Analytical sensitivity 3.4.1 RBP kit When testing a sample with a concentration of 50.0 mg/L, the absorbance difference (ΔA) should be ≥0.05. 3.4.2 URBP kit When testing a sample with a concentration of 1.0 mg/L, the absorbance difference (ΔA) should be ≥0.01. 3.5 Accuracy Accuracy should meet one of the following requirements.
...

Refund Policy Privacy Policy Terms of Service